Commonwealth Equity Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.01M Buy
59,503
+10,393
+21% +$692K 0.01% 1582
2026
Q1
$3.08M Buy
49,110
+17,134
+54% +$1.19M ﹤0.01% 1676
2025
Q4
$2.12M Buy
31,976
+4,268
+15% +$276K ﹤0.01% 1924
2025
Q3
$1.86M Sell
27,708
-5,406
-16% -$428K ﹤0.01% 2057
2025
Q2
$2.89M Sell
33,114
-14,464
-30% -$1.13M ﹤0.01% 1718
2025
Q1
$3.25M Buy
47,578
+3,197
+7% +$261K ﹤0.01% 1582
2024
Q4
$3.45M Sell
44,381
-1,562
-3% -$116K 0.01% 1479
2024
Q3
$3.08M Sell
45,943
-4,483
-9% -$368K ﹤0.01% 1556
2024
Q2
$5.72M Sell
50,426
-1,690
-3% -$214K 0.01% 1113
2024
Q1
$7.23M Buy
52,116
+4,711
+10% +$592K 0.01% 951
2023
Q4
$5.88M Buy
47,405
+3,636
+8% +$371K 0.01% 1012
2023
Q3
$4.08M Buy
43,769
+635
+1% +$71.6K 0.01% 1141
2023
Q2
$5.54M Buy
43,134
+7,905
+22% +$956K 0.01% 977
2023
Q1
$4.09K Sell
35,229
-3,451
-9% -$386K 0.01% 1114
2022
Q4
$4.38M Sell
38,680
-277
-0.7% -$30.4K 0.01% 1034
2022
Q3
$3.14M Sell
38,957
-1,757
-4% -$149K 0.01% 1145
2022
Q2
$3.03M Buy
40,714
+3,506
+9% +$320K 0.01% 1167
2022
Q1
$4.76M Sell
37,208
-9,232
-20% -$1.01M 0.01% 964
2021
Q4
$6.23M Sell
46,440
-1,832
-4% -$263K 0.01% 818
2021
Q3
$6.6M Buy
48,272
+13,708
+40% +$1.73M 0.02% 722
2021
Q2
$3.69M Buy
34,564
+176
+0.5% +$16.9K 0.01% 1027
2021
Q1
$3.09M Sell
34,388
-4,172
-11% -$392K 0.01% 1046
2020
Q4
$3.56M Sell
38,560
-25,196
-40% -$2.25M 0.01% 900
2020
Q3
$6.57M Buy
63,756
+27,124
+74% +$2.83M 0.02% 564
2020
Q2
$3.71M Buy
36,632
+7,400
+25% +$662K 0.01% 717
2020
Q1
$1.97M Buy
29,232
+5,508
+23% +$343K 0.01% 909
2019
Q4
$1.3M Buy
23,724
+304
+1% +$14.4K ﹤0.01% 1269
2019
Q3
$873K Buy
23,420
+856
+4% +$33.3K ﹤0.01% 1444
2019
Q2
$845K Buy
22,564
+6,752
+43% +$212K ﹤0.01% 1450
2019
Q1
$470K Buy
15,812
+2,028
+15% +$71.3K ﹤0.01% 1791
2018
Q4
$412K Sell
13,784
-4,572
-25% -$145K ﹤0.01% 1779
2018
Q3
$656K Buy
18,356
+8,584
+88% +$266K ﹤0.01% 1604
2018
Q2
$232K Buy
+9,772
New +$207K ﹤0.01% 2338
2017
Q4
Sell
-16,328
Closed -$200K 2690
2017
Q3
$200K Sell
16,328
-5,088
-24% -$89.9K ﹤0.01% 2288
2017
Q2
$392K Buy
21,416
+7,532
+54% +$139K ﹤0.01% 1731
2017
Q1
$294K Buy
13,884
+268
+2% +$5.23K ﹤0.01% 1868
2016
Q4
$203K Buy
13,616
+3,232
+31% +$57.3K ﹤0.01% 2043
2016
Q3
$228K Buy
+10,384
New +$231K ﹤0.01% 1912
2016
Q1
Sell
-10,332
Closed -$212K 2224
2015
Q4
$212K Buy
+10,332
New +$215K ﹤0.01% 1835

Other funds holding DXCM

Commonwealth Equity Services's DXCM Position: Q2 2026 in Review

Commonwealth Equity Services increased its DexCom (DXCM) stake by 21% in Q2 2026, buying an estimated $692K and bringing the position to 59,503 shares worth $4.01M. The position accounts for 0.01% of the portfolio, ranked #1582.

Commonwealth Equity Services first reported a position in DXCM in Q4 2015 and has held it in 39 quarters since. The position peaked at $7.23M in Q1 2024. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Commonwealth Equity Services held 59,503 shares of DexCom worth $4.01M as of Q2 2026.
  • Commonwealth Equity Services bought 10,393 DexCom shares in Q2 2026, an estimated $692K.
  • DexCom made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1582 holding.
  • Commonwealth Equity Services first reported a position in DexCom in Q4 2015 and has held it in 39 quarters since.
  • Commonwealth Equity Services's DexCom position peaked at $7.23M in Q1 2024.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.